Amesite Insiders Lead $600K Private Placement at $1.435, Boost Equity Above $2.5M
Amesite's officers and directors purchased 418,118 shares and Series A-1/A-2 warrants at $1.435 each in an insider-led private placement, generating $600,000 gross proceeds. Combined with a concurrent $2 million offering, the company expects stockholders’ equity to exceed $2.5 million to regain Nasdaq compliance.
1. Private Placement Details
Amesite entered into definitive agreements with officers and directors, including its CEO and a board member, to sell 418,118 common shares and an equal number of Series A-1 and A-2 warrants at $1.435 per share. The insider-led tranche is expected to close on April 28, 2026, yielding approximately $600,000 in gross proceeds.
2. Warrant Terms and Conditions
The Series A-1 and A-2 warrants have an exercise price of $1.435 per share and differ in expiration: A-1 warrants expire five years after the later of the Resale Registration Statement effectiveness or stockholder approval, while A-2 warrants expire eighteen months after those milestones.
3. Combined Financing and Nasdaq Compliance
This insider-led placement complements a concurrent registered direct offering expected to raise $2 million. Upon closing both financings, Amesite anticipates stockholders’ equity will surpass $2.5 million, satisfying Nasdaq’s minimum equity requirement for continued listing.